Retatrutide is a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating these receptors, https://georgiaqbac840993.blog-ezine.com/36439932/tirzepatide-a-promising-new-treatment-for-obesity